Introduction
The neurotrophic factors (NTF) are peptides playing important roles in the developing and in the adult brain. Alterations in NTF expression patterns in different physio-pathological situations and NTF effects in the adult brain (e.g axonal sprouting induction and neuroprotection) suggest their involvement in neuronal plasticity. [1] [2] [3] Among these peptides, one of the best studied is the fibroblast growth factor-2 (FGF-2, basic FGF, bFGF), the prototype of a family of heparin binding growth factors. 4 FGF-2 is found at relatively high concentrations in the developing and in the adult brain, 5, 6 and has strong trophic effects in central nervous system neurons and astrocytes. 7, 8 FGF-2 has been shown to be implicated in the maturation, as well as in the survival and reorganization of neurons in the adult brain after injury. 9, 10 Furthermore, FGF-2 is transiently expressed in the hippocampus and cortex following generalized seizures [11] [12] [13] and during epileptogenesis.
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It is still uncertain whether increased expression of NTFs per se is sufficient to induce changes in the function of brain cell populations, thus protecting from, or favoring, the development of specific neurological diseases. The intracerebral infusion of NTFs represents a pharmacological approach to this problem. However, this approach is hindered by several limitations, including the correct calibration of doses and times of exposure, and the possibility that some NTFs (for example FGF-2) may exert intracrine effects. 16 One alternative approach may be based on the use of viral vectors to transfer NTF genes to specific brain cell populations. Herpes simplex virus (HSV) vectors have been used to transfer many different genes into a variety of cell types, [17] [18] [19] including neurons. [20] [21] [22] HSV-1 is a human neurotropic virus, which is capable of infecting mature neurons and establishing a latent or a quiescent infection in these cells, as part of the natural biology of the virus. 23, 24 During latency, the viral genome persists as a transcriptionally silent episomal molecule, except for the expression of a series of latency-associated transcripts (LATs). 25, 26 Lytic viral gene expression is not required for the virus to establish latency 27 and thus, replicationdefective HSV-1 vectors can be used for gene transfer and expression in neurons. Furthermore, the HSV-1 genome (152 kb) can be manipulated to contain large amounts of foreign DNA (up to approximately 30 kb).
Our laboratories have focused on the development of HSV vectors that are defective in essential viral functions and fail to replicate without complementation of the deleted genes. The choice of mutations that prevent virus replication and its effect on transgene expression is an important consideration for vector design. It is essential to select a vector background that does not immediately cause cell death with the loss of transgene product formation. Mutants deleted for single essential immediateearly (IE) genes are cytotoxic to neurons in culture, even though they express only the remaining viral IE genes in substantial amounts. In tissue culture, viral mutants simultaneously deleted for ICP4, ICP22 and ICP27 are substantially less cytotoxic than viruses deleted for ICP4 alone or ICP4 in combination with ICP27. 28, 29 The elimination of ICP0 in addition to these genes renders the virus largely innocuous to cells at relatively high multiplicities of infection, indicating that the expressed viral functions account for viral toxicity, and that viral structural proteins play a minor role. 30 Although these mutations eliminated vector toxicity, transgene expression also rapidly declined, suggesting that some viral function (eg ICP0) may be required for efficient transduction. We have recently reported that replication-incompetent HSV-1 vectors deleted for the three IE genes, ICP4, ICP22 and ICP27, are substantially reduced in cytotoxicity for infected primary cortical and dorsal root ganglia neurons, and both HSV-1 ICP0 IE or human cytomegalovirus (HCMV) IE promoters remained active for over 14 days after infection. 29 The ability to infect neurons efficiently in culture without obvious damage or silencing of reporter gene expression suggests that multiply deleted HSV vectors may be useful to express therapeutic genes in neurons. However, the vectors employed thus far 28 were designed to express reporter genes only.
In this study, we report the construction and the use of two replication-defective HSV vectors, SH FGF-2 and TH FGF-2, which efficiently transfer and express in cell lines the cDNA for a potentially therapeutic, constitutively expressed gene (FGF-2). The time-course of vectorproduced FGF-2 gene expression has been studied in vitro in Vero cells and in vivo after injection in the rat hippocampus. Furthermore, the biological activity of this newly synthesized FGF-2 and the toxic effects of the vectors have also been evaluated.
Results

Construction of FGF-2 expression vectors
The vectors SH FGF-2 and TH FGF-2 ( Figure 1 ) were created in two steps. First, the bacterial lacZ gene, under the control of the HCMV IE promoter and flanked by PacI restriction sites (which are not present in the viral genome), was inserted into the thymidine kinase locus of the two replication-deficient vectors S4TK or T.2, defective for the ICP4 or the ICP4/ICP27/ICP22 genes respectively, generating SH lacZ or TH lacZ. Subsequently, using the PacI system (see Materials and methods), the transgene was introduced into the tk locus of the SH lacZ or TH lacZ vectors by digestion of the viral DNA and by homologous recombination with an expression cassette containing sequences coding for FGF-2 under the control of the HCMV IE promoter. The HCMV IE promoter has been previously shown to express transgenes efficiently. 31 
Expression of the FGF-2 transgene in vitro
To evaluate whether cells infected with SH FGF-2 or TH FGF-2 recombinant viruses could express FGF-2 and to quantify the intracellular transgene levels, Western blot and ELISA assays were performed on total proteins extracted from Vero cell monolayers infected with either SH FGF-2 or TH FGF-2 at a multiplicity of infection (MOI) of 1.0. A first set of experiments was run 24 h after infection. As determined by Western blot, FGF-2 expression was more elevated in SH FGF-2 and TH FGF-2 infected cells than in control Vero uninfected cells ( Figure 2) . As determined by an ELISA test based on the use of an anti-FGF-2 monoclonal antibody, the amount of FGF-2 was 6200 pg/10 6 cells for the single mutant vector (SH FGF-2), 3000 pg/10 6 cells for the triple mutant (TH FGF-2), and 80 pg/10 6 cells for TH lacZ infected cells and Vero uninfected cells. Interestingly, SH lacZ produced a significant increase in FGF-2 levels (300 pg/10 6 cells).
Thus, one day after infection, the transgene was expressed at higher efficiency using the single compared with the triple mutant, and the FGF-2-induced expression was, respectively, 78 and 38 times higher than endogenous FGF-2 (Vero uninfected cells). Figure 3 shows data obtained using ELISA: in cells infected with TH FGF-2 we observed a prolonged expression of FGF-2 up to 7 days (4000 pg/10 6 cells) with maximal expression at 3 days (5500 pg/10 6 cells), whereas in cells infected with SH FGF-2 the expression of the transgene dropped to the level of control SH lacZ infected cells after 4 days, with maximal expression at 2 days (6800 pg/10 6 cells). In keeping with data at 24 h, SH lacZ (but not TH lacZ) also induced some FGF-2 overexpression during the first 2 days p.i. (Figure 3 ). All these data were confirmed in a Western blot analysis (data not shown). This indicates that the multiply deleted recombinant virus TH FGF-2 expresses the transgene for a longer time in vitro than the SH FGF-2 vector, which is deleted only for ICP4.
Neurite outgrowth from PC12 cells
To determine if biologically active FGF-2 protein was expressed by the transduced cells, we infected Vero cells with TH lacZ or TH FGF-2 (MOI of 1.0) and the clarified cellular lysate was tested for its ability to induce neurite outgrowth in PC12 cells. As shown in Figure 4 , clear neurite outgrowth was observed in PC12 cultures treated from TH FGF-2 infected cells but not from mock or control infected cultures. These data demonstrate that the recombinant FGF-2 was able to induce morphological differentiation of undifferentiated neuronal cells.
Expression of the FGF-2 transgene in vivo FGF-2 gene expression has been studied in vivo after stereotactical inoculation of vectors in the right hippocampus of the rat. FGF-2 is constitutively expressed in several cell populations of the hippocampus, most prominently in CA2 pyramidal neurons and in astrocytes. 13 Therefore, the left, non-injected hippocampus has been employed as an internal control, to allow a precise measurement of the relative increase in gene expression induced by the different vectors.
::HCMV IEp-FGF2). The single mutant SH FGF-2 and the triple mutant TH FGF-2 are replication deficient due to the deletion of the essential ICP4 or ICP4 and ICP27 genes, respectively. TH FGF-2 has also a third deletion in the non-essential ICP22 gene. The two recombinant vectors contain the FGF-2 transgene under the control of the HCMV IE promoter (HCMV IEp) in the tk locus. Vertical bars indicate deletions.
Figure 2 Western blot analysis of FGF-2 expression 24 h after infection of Vero cells with SH FGF-2 and TH FGF-2 vectors or in control uninfected cells. Equal amounts of cell lysates were electrophoresed on a 12% SDS-PAGE, transferred to nitrocellulose and probed with monoclonal antiserum direct against human FGF-2. The level of FGF-2 protein was
TH FGF-2 (5 × 10 5 p.f.u.) induced a significant relative increase in FGF-2 protein levels, as compared with TH lacZ ( Figure 5 ). Three protein isoforms were identified in Western blot analysis, in accordance with previous reports. 32 All three isoform levels were increased to a similar extent after TH FGF-2 injection. A kinetics analysis was run by examining FGF-2 levels 4, 7, 15 and 30 days after vector injection: maximal increases have been observed at 4 days, while a lower, nonsignificant increase was still present at 7 days, and levels returned to baseline by 15 days (Figure 5b) .
In situ hybridization experiments have been performed to identify the cell populations overexpressing FGF-2 mRNA, using a time-point preceding the maximal
Figure 3 Time-course of FGF-2 expression in vitro as determined by ELISA. The FGF-2 expression was assayed on clarified lysates from SH FGF-2, TH FGF-2, SH lacZ and TH lacZ infected Vero cells (1 p.f.u. per cell) using an anti-human FGF-2 monoclonal antibody. Cells were harvested every 24 h up to 7 days. Each point represents the average of three separate experiments.
increase observed with the Western blot analysis (3 days). In a 2-3 mm ray area adjacent to the tip of the infusion needle, a diffuse (presumably glial), highly significant (2.5-fold) increase in FGF-2 mRNA levels has been observed in the molecular layer of the dentate gyrus (Figures 6b and 7b ). Smaller increases in FGF-2 mRNA levels have also been observed over dentate granule and pyramidal neurons, but these increases reached significant levels only over dentate granule cells (Figures 6b  and 7b ). TH lacZ injection did not modify FGF-2 mRNA levels (Figures 6a and 7b ).
In order to evaluate possible toxic effects of TH vectors, sections adjacent to those employed for in situ hybridization have been stained with Cresyl Violet. A small lesion
Figure 4 PC12 cell differentiation in response to treatment with recombinant FGF-2. PC12 cells were treated with clarified cell lysates from mock (a), TH lacZ (b) or TH FGF-2 (c) infected Vero cells. PC12 cells showed significantly neurite outgrowth in response to recombinant FGF-2 (c) compared with cells treated with controls (a, b).
area with surrounding gliosis was observed around the infusion needle tip (Figure 6c ). Similar lesions were observed in rats injected with TH lacZ or TH FGF-2. However, the lesion area produced by TH FGF-2 inoculation was much smaller than the area displaying FGF-2 overexpression, ie no sign of cell damage could be observed over the vast majority of the cells overexpressing FGF-2 ( Figure 6d ). Furthermore, a certain degree of lesion was also observed in rats injected with saline, indicating the contribution of mechanical factors.
In contrast to TH FGF-2, SH FGF-2 did not significantly increase FGF-2 expression up to 5 × 10 6 p.f.u., as measured 2 days after injection using the Western blot analysis (Figure 5b ) and 1 day after injection using in situ hybridization (Figure 7a ). These early time-points were chosen on the basis of the kinetics of expression observed in vitro.
Discussion
Previous studies have demonstrated the potential utility of replication-incompetent HSV vectors to express foreign genes in neurons in vitro and in vivo. 33 'First gen- eration' defective genomic vectors were deleted in the single essential IE gene encoding ICP4 (eg d120 and S4TK). 34, 35 Although these vectors are of reduced pathogenicity and can be used efficiently to transfer and transiently express reporter genes in the brain, they are none the less cytotoxic for neurons in culture. Residual cytotoxicity may result from the expression of the other IE genes. ICP4, ICP27, ICP0 and ICP22 have all been shown to be toxic in stable transfection assays, 36 so deletion of these genes in combination is required to eliminate toxicity.
Figure 5 (a) Western blot analysis of hippocampal FGF-2 protein levels, as compared with the internal standard ␣-tubuline, in the right (injected) and left (control, non-injected) hippocampus, 4 days after infusion of TH FGF-2 or TH lacZ (5 × 10 5 p.f.u.). This 'representative' autoradiogram will not exactly match the mean values shown in (b) because of slight differences in the four animals of each group. (b) Time-course of the effect of intrahippocampal injection of SH FGF
Cell lines that complement ICP4 and ICP27 have permitted the construction of 'second generation', highly defective mutants. 28, 37 Compared with mutants deleted for single IE genes, these multiply deleted mutants show substantially reduced cytotoxicity for neurons in culture and unusually prolonged transgene expression from the ICP0 IE promoter or the HCMV IE promoter in neurons in vitro. 29 To date, several replication-defective vectors have been constructed in which ICP0, ICP4, ICP27 and ICP22 genes have been deleted in various combinations. 28, 29, 37 Deletion of all IE genes prevents virus toxicity for cells at a high multiplicity of infection, allowing the vector gene to persist in cells for long periods. 30 However, elimination of ICP0 in the vector background also dramatically reduced the level of transgene expression in Vero and HEL cells. 29 In contrast to the completely defective mutant, efficient expression of the trangene was possible using mutants lacking ICP4, ICP27 and ICP22. 28, 29, 37 This mutant background contains residual toxicity for some cell types, arresting cell division in both the S and G2 phase. 37 Krisky et al 29 have reported similar findings, although the arrest of cell viability and cell division was found to be transient at low multiplicity infections, and primary neuronal cells were less sensitive to the toxic effects of ICP0, permitting cell viability and continuous transgene expression for at least 3 weeks in culture. These data suggest that the triply deleted vector will be useful for gene transfer applications involving high level, but short-term, transgene expression in nonneuronal cells, but should provide a suitable vector platform for long-term expression in neurons.
We applied vectors of the first and the second generation to the study of expression of FGF-2 both in vitro, in cell cultures of epithelial and neuronal origin, and in vivo, in an animal system. Our in vitro data are in keeping with the above observations. In Vero cells, which have relatively little constitutional FGF-2 expression, both SH FGF-2 and TH FGF-2 greatly increased the production of this trophic factor. A longer-lasting FGF-2 overexpression was obtained using TH FGF-2 than using SH FGF-2; during the first 2 days after infection, however, SH FGF-2 appeared to induce FGF-2 expression more strongly than TH FGF-2. Most likely, these differences between the two vectors can be ascribed to the high toxicity of SH FGF-2. In fact: (1) SH lacZ has been found to be highly cytotoxic: Vero cell survival 2 days after infection at a MOI of 3.0 was 2%, and primary neuronal cultures were killed within 24 h; 29, 37 (2) SH lacZ per se produced a significant increase in endogenous FGF-2 in Vero cells in the first 2 days after infection; and (3) significant amounts of FGF-2 have been found in the supernatant of cells infected with SH vectors. Taken together, these data suggest that the single mutant causes some degree of cytotoxicity-induced FGF-2 production, and that newly-produced FGF-2 is released in the medium after cell death.
In contrast, TH FGF-2 induced a slower-increasing, longer-lasting FGF-2 expression. This effect was exerted in the presence of little cytotoxicity because: (1) after infection of T.2 (the parent vector of TH lacZ) at a MOI of 3.0, Vero cell survival at 2 days was 60-90% and primary neuronal cultures survived up to 2 weeks; 29, 37 (2) TH lacZ per se did not produce any increase in endogenous FGF-2 in Vero cells in the first week after infection; and (3) negligible amounts of FGF-2 have been found in the supernatant of cells infected with TH vectors. Finally, the newly-synthesized FGF-2 was biologically active, since it was capable of inducing neuronal differentiation of PC12 cells.
TH FGF-2 was much more efficient than SH FGF-2 in 
u. SH FGF-2 or SH lacZ (a), and 3 days after injection of 5 × 10 5 p.f.u. TH FGF-2 or TH lacZ (b) in the right hippocampus. The results are expressed as percentage of control signal (in the contralateral, non-injected hippocampus) over the dentate gyrus (DG) molecular layer, the DG granular layer, and the CA3, CA2, CA1 pyramidal layers. Data are the mean ± s.e. of four independent experiments. *P Ͻ 0.05, **P Ͻ 0.01 versus TH lacZ injected (Student's t test for non-paired data).
gene transduction in vivo, in that it produced a robust, transient expression of the transgene. Expression of the transgene (and not induction of endogenous FGF-2) is indicated by the lack of effect of TH lacZ on FGF-2 mRNA and protein levels. Transgene expression was robust in that FGF-2 protein increased by approximately 50% in Western blot analysis, and FGF-2 mRNA increased by 50-250% (depending on the region/cell population examined) in in situ hybridization. Most likely, this latter estimate of the effect of TH FGF-2 is more accurate, since Western blot data are based on homogenates of the whole hippocampus, while the transgene expression, as demonstrated by the in situ hybridization data, is limited to a small area around the injection site. Given the relatively high FGF-2 constitutive expression, this increase is noteworthy.
FGF-2 overexpression in vivo was transient, yet lasting for more than 1 week (in keeping with in vitro data). This time lag is probably sufficient to prime lasting plastic changes. Interestingly, transgene expression was found in a region (the molecular layer of the dentate gyrus) where FGF-2 constitutional expression is relatively low. This observation was made consistently in all injected animals, independent of the precise localization of the needle tip which, however, was always close to the granular layer. Of course, this may indicate localization on glial cells. However, another hypothesis may be that the FGF-2 mRNA is targeted to dendrites, as occurs with brain-derived growth factor (BDNF) in hippocampal neurons in vitro, in an activity-dependent manner. 38 Further studies will be needed to clarify this point.
Importantly, these effects of TH FGF-2 were produced in the presence of apparently limited toxicity, as expected on the basis of: (1) in vitro data and effect of TH lacZ in vivo (low toxicity of the virus per se); and (2) the mechanical damage produced by the needle and by the injection (saline-injected controls). In contrast to TH FGF-2, SH FGF-2 did not significantly increase FGF-2 mRNA or protein levels, even when injected in higher amounts. Most likely, this lack of effect of SH FGF-2 depends on its toxicity, which may also account for a modest, nonsignificant increase in FGF-2 levels. In fact, such modest increase in FGF-2 levels is also observed after injection of SH lacZ and, therefore, is likely to be dependent upon reactive (post-lesional) increases in endogenous FGF-2 levels, and not on transgene expression.
Taken together, the data presented suggest that the replication-defective HSV mutant TH FGF-2 may be useful for studies of the effects of FGF-2 in the adult brain in vivo, in that it produces a robust, transient elevation in FGF-2 levels within selected cell populations. For example, TH FGF-2 may be particularly useful in the study of epileptogenesis, where a transient increase in FGF-2 levels has been found within selected cell populations.
14 Other future research directions will include analysis of TH FGF-2 effects on neurodegeneration in vitro and in vivo, and on the electrophysiology of hippocampal slices ex vivo. Furthermore, TH FGF-2 may form the basis for a new generation of less toxic mutants inducing longer-lasting FGF-2 expression, which may be appropriate for gene therapy of neurodegenerative diseases.
Materials and methods
Cell culture and virus stock production Vero, African green monkey kidney cells (ATCC, Rockville, MD, USA; CCL81) and 7B cells 35 were maintained in Dulbecco's modified essential medium (DMEM, EuroClone Ltd, Cramlington, UK) supplemented with glutamine, antibiotics (PSN) and 10% fetal calf serum (FCS). PC12, rat pheochromocytoma cells (ATTC, CRL-1721), were maintained in RPMI medium supplemented with 10% FCS. Virus stocks were prepared as previously described. 39 
Plasmid and vector constructions
Plasmids pTK-HCMV-lacZ and pTK-HCMV-FGF-2: The reporter construct consisted of lacZ gene upstream of the SV40 polyadenylation signal flanked by PacI restriction sites. In the plasmid the reporter gene, under the control of the HCMV IE promoter (size 763 bp), was placed within the tk coding sequences to allow for the homologous recombination of the expression cassette into the viral genome. 31 The sequences for the rat ovarian FGF-2 cDNA (A Baird, The Whittier Institute, La Jolla, CA, USA) were placed downstream of the HCMV IE promoter and 5Ј to the polyadenylation sequences from the bovine growth hormone gene. This expression cassette was cloned into a plasmid containing the sequences from the tk locus.
Vectors SH lacZ and TH lacZ: The vector SH lacZ (SH/tk − ::HCMV-lacZ) was created by recombining the lacZ expression cassette described above into the tk locus of the ICP4 − replication defective mutant S4TK using the previously described PacI recombination method.
35 S4TK is deleted for both copies of the gene encoding the IE protein ICP4, and therefore incapable of replicating in non-complementary cells that do not provide the essential ICP4 gene product in trans. S4TK differs from the original d120 ICP4 null mutant 34 due to the replacement of the HSVtk (U L 23) endogenous promoter with the ICP4 IE promoter. This modification also results in deletion of the U L 24 gene. The vector TH lacZ (TH/tk − ::HCMV-lacZ) was generated by inserting a HCMV-lacZ expression cassette in the tk locus of a recombinant mutant deleted of ICP4, ICP27 and ICP22 IE genes (T.2), 37 and therefore incapable of replicating in cells that do not express the essential ICP4 and ICP27 genes in trans. The lacZ reporter construct was introduced into the genome of the two vectors by homologous recombination, as previously described. 31 Briefly, S4TK or T.2 genome DNAs were cotransfected with 1 g linearized pTK-HCMV-lacZ plasmid, containing the lacZ gene flanked by unique PacI sites within the tk viral sequences, using the CaPO 4 method on to monolayers of 7B cells in 60 mm culture plates. Recombinant viruses created by the disruption of tk and its replacement by the lacZ expression cassette were identified by their blue plaque phenotype after X-gal staining.
Vectors SH FGF-2 and TH FGF-2: Vectors SH FGF-2 (SH/tk − ::HCMV-FGF-2) and TH FGF-2 (TH/tk::HCMV-FGF-2) were generated by homologous recombination between SH lacZ or TH lacZ viral DNAs and the plasmid pTK/HCMV-FGF-2 using the PacI recombination system as described above. 35 Recombinants containing FGF-2 in place of lacZ reporter gene were identified by their clear plaque phenotype after X-gal staining. Recombinant viruses from individual plaques were purified to homogeneity by three rounds of limiting dilution, and the presence of the transgene in place of lacZ was identified by Southern blot analysis.
Animals
Male Sprague-Dawley rats (300-350 g; Stefano Morini, Reggio Emilia, Italy), were used for all in vivo experiments. Animals were housed under standard conditions: constant temperature (22-24°C) and humidity (55-65%), 12 h dark-light cycle, free access to food and water. Procedures involving animals and their care were carried out in accordance with European Community and national laws and policies.
Expression of the FGF-2 transgene in vitro
Vero cells were plated in six-well plates (2 × 10 5 cells per well). One day after plating, some wells were infected at a MOI of 1.0 with SH FGF-2, TH FGF-2, SH lacZ or TH lacZ. One to 7 days after infection, individual cell monolayers were scraped in Tris-buffered saline (TBS), the cell pellet treated with lysis buffer (0.1 m NaCl, 0.01 m Tris-HCl pH 7.0, 0.001 EDTA pH 8.0, 1% Triton X-100, 1 g/ml aprotinin, 100 g/ml PMSF), sonicated and cleared by centrifugation. The presence of FGF-2 in the supernatant was determined by Western blot and ELISA assays.
Western blot assay: Aliquots of infected cell extracts were mixed with electrophoresis sample buffer (final concentration = 100 mm Tris-HCl pH 6.8, 200 mm dithiothreitol (DTT), 4% SDS, 0.2% bromophenol blue, 20% glycerol), boiled for 3 min and subjected to sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE).
Proteins were separated on a 12% SDS-PAGE gel, and transferred to reinforced nitrocellulose (Optitran BA-S 83; Schleicher & Schuell, Dassel, Germany) in Tris-glycinemethanol buffer. Nitrocellulose was blocked with blocking buffer (10 mm Tris-Cl pH 7.4; 0.15 m NaCl; 5% skim milk; 0.05% NaN 3 ) for 3 h at 4°C and then incubated overnight at 4°C with an anti-human FGF-2 mouse MAb (Transduction Laboratories, Lexington, KY, USA) diluted 1:250 in blocking buffer containing 1% BSA and 0.05% NP40 or with an anti-␣-tubuline antibody (Sigma Chemical, St Louis, MO, USA) diluted 1:1000 in blocking buffer. Three 15 min washes were performed with wash buffer (10 mm Tris-Cl pH 7.4; 150 mm NaCl; 0.3% NP40) and nitrocellulose was incubated with an anti-mouse horseradish peroxidase-conjugate MAb (Amersham Life Science Italia, Milan, Italy) diluted 1:5000 in wash buffer. Detection was accomplished with ECL+Plus detection reagents (Amersham Life Science Italia). Different exposure times were used for FGF-2 and for ␣-tubuline, in order to ensure that the autoradiographic bands were in the linear range of intensity.
The levels of FGF-2 protein isoforms were calculated by measuring the optical densities of autoradiographic bands with a RBR Altair densitometry system (Firenze, Italy). Background densities from areas of film away from the lanes were subtracted from observed values. Data were then normalized against the optical density of the ␣-tubuline band, and expressed as percent of control.
ELISA: Direct quantification of FGF-2 was determined using an ELISA kit (R&D System, Minneapolis, MN, USA) in which 96-well microplates were coated with a monoclonal anti-human FGF-2, which cross-reacts with the rat FGF-2. Briefly, 200 l of the FGF-2 standard and the supernatants or the clarified lysates from SH FGF-2, TH FGF-2, SH lacZ, TH lacZ infected cells and Vero uninfected cells were added to each well, and the plates were incubated for 2 h at room temperature. After washing, 200 l of peroxidase-conjugate monoclonal anti-human FGF-2 were added to each well. Incubation was continued for 2 h at room temperature. After washing, enzymatic activity was detected by adding the substrate solution for 20 min at room temperature. Absorbance values were measured at 450 nm using a microtiter plate spectrophotometer (Titertek Multiskan, Flow Laboratories, Irvine, UK).
PC12 neurite outgrowth
Vero cells were infected at a MOI of 1.0 with either TH FGF-2 or TH lacZ, or left untreated. Forty-eight hours after infection, cell monolayers were harvested, treated with the lysis buffer and centrifuged to discard cellular debris. The supernatants obtained from the cell lysates were stored at −20°C and subsequently used to test the effect of the recombinant FGF-2 on PC12 cells. Approximately 1.5 × 10 5 PC12 cells were plated in 60 mm dishes in the presence of RPMI medium added with 2% fetal bovine serum (FBS). One day after plating, some cultures were added with the lysate obtained from TH FGF-2 infected Vero cells, TH lacZ infected Vero cells or Vero mock infected cells. Each 4-5 days, the medium was changed with fresh medium added with cell lysates and the cells were examined using an inverted Nikon microscope for neurite outgrowth.
Expression of the FGF-2 transgene in vivo HSV infusion in vivo: Under ketamine (100 mg/kg i.p.) anesthesia, a needle connected to a perfusion pump was implanted in the right hippocampus (coordinates: 4.9 mm lateral and 3.6 mm posterior to bregma, 5.0 mm deep from dura). A total of 5 × 10 6 p.f.u. of SH FGF-2 or SH lacZ and 5 × 10 5 p.f.u. of TH FGF-2 or TH lacZ were injected in a volume of 8-10 l at a flow rate of 0.4 l/min. Rats were then allowed to recover, and killed 1-30 days thereafter for Western blot analysis or in situ hybridization.
Western blot analysis: Rats were killed by decapitation under light diethyl-ether anesthesia, and hippocampi were rapidly dissected. Tissues were then lysed by repeated strokes of a Dounce homogenizer in 500 l of suspension buffer (0.1 m NaCl; 0.01 m Tris-Cl pH 7.6; 0.001 m EDTA pH 8.0; 1 g/ml aprotinin; 100 g/ml PMSF). The protein content of the lysates was evaluated by the Lowry assay. 40 One milligram of each sample was diluted to 150 l with suspension buffer, 150 l of 2 × SDS-gel loading buffer (100 mm Tris-Cl pH 6.8; 200 mm dithiothreitol (DTT); 4% SDS; 0.2% bromophenol blue; 20% glycerol) were added and the samples were boiled for 10 min. The samples were then sonicated three times for 15 s and centrifuged for 10 min at 10 000 g at 4°C. Finally, 300 g (80 l) of each sample were loaded on to a 15% polyacrylamide gel crosslinked with N,NЈ-diallyltartardiamide (Bio-Rad Laboratories, Hercules, CA, USA). Protein transfer to nitrocellulose, incubation with antibodies, washings, detection and calculations were made as described above.
In situ hybridization: Rats were killed by decapitation under light diethyl-ether anesthesia, and their brains rapidly removed, frozen in isopentane cooled in a dry ice/methanol bath, and stored at −70°C until use. Twenty m coronal sections at the level of the dorsal (plate 39) 41 and ventral hippocampus (plate 50) 41 were thawmounted on to polylysine coated slides, fixed in paraformaldehyde 4%, soaked in phosphate saline buffer (PBS) for 10 min at room temperature, then rinsed in a graded ethanol series and dried. Sections were stored at −70°C until use. Immediately before in situ hybridization, they were pretreated with proteinase K (1 g/l in Tris-EDTA buffer) for 10 min at 37°C and with acetic anhydride 0.25% v/v for 10 min at room temperature.
The FGF-2 riboprobe was obtained using the plasmid RObFGF103 (A Baird) containing a 1016 bp portion of rat FGF-2 cDNA. The plasmid was linearized with NcoI and transcribed with T7 RNA polymerase to obtain antisense riboprobes, or with T3 RNA polymerase to obtain sense riboprobes. All riboprobes were obtained by running the respective transcription assays in the presence of ␣ 33 PrUTP (NEN Life Science Products, Boston, MA, USA), and hydrolyzed to fragments of approximately 200 base pairs with sodium carbonate at 60°C.
In situ hybridization was performed as previously described. 42 The in situ hybridization mixture contained 50% deionized formamide, 0.6 m NaCl, 2 mm EDTA, 20 mm Tris (2 × NTE), 5 × Denhardt's solution, 100 g/ml ssDNA, 100 g/ml tRNA, 0.05% sodium pyrophosphate and 60 ng/ml 33 P-riboprobe. Sections were incubated overnight at 52°C with 40 l hybridization mixture. Following hybridization, they were rinsed twice for 10 min in 4 × SSC (0.6 m NaCl, 0.06 m citric acid) and treated with RNase A (20 g/ml) for 30 min at 37°C. Sections were then rinsed in 1 × SSC for 10 min, 0.1 × SSC at 52°C for 30 min, 0.1 × SSC at room temperature for 10 min, and dehydrated through an ethanol series. Autoradiograms were generated by apposing these dried sections alongside After development of the film, a digital analysis system (RBR Altair) was used to obtain optical density measurements over structures of interest in the autoradiogram. The mean total optical density within a particular area was calculated by multiple sampling of that area in four sections taken from each animal. Background (nonspecific) hybridization was estimated using other sections incubated with the sense probe, and subtracted from the calculated values of total optical density. These specific optical density measurements were then compared with those obtained from the 33 P-riboprobe standards to convert OD units into units of mole/mm 2 . 43 By using this method of standardization, small differences in OD resulting from differences in film development were corrected, allowing values obtained from homologous regions to be compared across different films. Finally, data have been expressed as percent of controls (contralateral hippocampus).
Cresyl Violet staining
Brain sections at the level of the ventral hippocampus (adjacent to those employed for in situ hybridization) were prepared and post-fixed as described for in situ hybridization. They were then passed through 0.5% Cresyl Violet for 5 min, 95% ethanol for 30 s, 100% ethanol for 1 min, and xylene for 30 s. Coverslips were mounted using Entellan (Merck, Dermstadt, Germany). tutes of Health: 1RO1NS35659-01A2, 5RO1GM34534-15, 5PO1DK44935-03, 5RO1DK49095-02 and by a grant from GenVec, Inc, Rockville, MD. The authors thank Iva Pivanti for technical assistance.
